Tasigna (nilotinib) in chronic myeloid leukemia treatment-free remission after nearly 2 years: An interview with Adam Mead by Mead, A

Single-cell approaches reveal novel cellular pathways for megakaryocyte and erythroid differentiation by Psaila, B, Mead, A

Myeloproliferative neoplasm stem cells by Mead, A, Mullally, A

Application of single-cell genomics in cancer: promise and challenges. by Wills, Q, Mead, A

Heterogeneity in myeloproliferative neoplasms: causes and consequences by O'Sullivan, J, Mead, A

Loss of bone marrow mesenchymal stem cells in myeloproliferative neoplasms as an indicator of niche dysregulation by Bishop, E, Mead, A, Soilleux, EJ

Ruxolitinib is effective in patients with intermediate-1 risk myelofibrosis: a summary of recent evidence by Harrison, C, Talpaz, M, Mead, A

Germline counterparts of oncogenic mutations: who gives a JAK?. by Mead, A, Constantinescu, SN, Jacobsen, SE

Adult idiopathic thrombocytopenic purpura. by Mead, A, Newland, A, Provan, D

Single cell analysis of normal and leukemic hematopoiesis by Povinelli, B, Rodriguez-Meira, A, Mead, A

Anaesthesia for the laser treatment of neonates with retinopathy of prematurity. by Mead, A, Chen, S, Wilkinson, A, Patel, C

Statistical principles for the design of experiments / by Mead, R. (Roger), Gilmour, S. G., Mead, A. (Andrew)

Allogeneic Stem Cell Transplantation for Myelofibrosis in 2012 by Mclornan, D, Mead, A, Jackson, G, Harrison, C

Germline JAK2 mutation in a family with hereditary thrombocytosis. by Mead, A, Rugless, M, Jacobsen, SE, Schuh, A

Real‐world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study... by Milojkovic, D, Cross, NCP, Ali, S, Mead, A, Et al.

Allogeneic stem cell transplantation for myelofibrosis in 2012. by McLornan, D, Mead, A, Jackson, G, Harrison, C

Equivalence of BCSH and WHO diagnostic criteria for ET by Harrison, C, McMullin, M, Green, A, Mead, A

A physician survey on the application of the British Society for Haematology guidelines for the diagnosis and management of myelofibrosis in the UK by Harrison, C, Mead, A, Drummond, M, Chiu, G, Bains, R

Repeated ECS differentially affects rat brain 5-HT1A and 5-HT2A receptor expression. by Burnet, P, Mead, A, Eastwood, S, Lacey, K, Harrison, P, Sharp, T

Shared care protocol for the management of essential thrombocythaemia patients in primary care by Sweeney, C, Roy, N, Mead, A, Wainscoat, J, Vyas, P